AstraZeneca Receivables 2010-2024 | AZN

AstraZeneca receivables for the quarter ending September 30, 2024 were $13.547B, a 12.92% increase year-over-year.

  • AstraZeneca receivables for 2023 were $13.552B, a 20.44% increase from 2022.
  • AstraZeneca receivables for 2022 were $11.252B, a 9.17% increase from 2021.
  • AstraZeneca receivables for 2021 were $10.307B, a 39.55% increase from 2020.

AstraZeneca Receivables 2010-2024 | AZN

  • AstraZeneca receivables for 2023 were $13.552B, a 20.44% increase from 2022.
  • AstraZeneca receivables for 2022 were $11.252B, a 9.17% increase from 2021.
  • AstraZeneca receivables for 2021 were $10.307B, a 39.55% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B